Ainos Q1 2026: operating expenses down 30% to $2.28M, secures $2.8M financing, progresses AI Nose deployments

Ainos, Inc.

2026-Q1 EPS reported -$0.41 revenue$161

Operating expenses declined ~30% YoY to approximately $2.28 million for Q1 2026.
Strengthened balance sheet with NT$90 million (~$2.8 million) financing arrangement during the quarter.
Continued deployment under $2.1M commercial arrangement in backend semiconductor environments targeting ~1,400 AI Nose systems.
Initiated pilot and validation activities in front-end semiconductor environments and expanded distribution partnership.
Expanded AI Nose into healthcare infrastructure settings including hospital utility, HVAC, and MRI environments.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.92

Ainos, Inc. reported financial results for the first quarter ended March 31, 2026.

Period: the first quarter ended March 31, 2026
Result: reported results

Exact text from the filing

On May 13, 2026, Ainos, Inc. (the “Company”) reported its financial results for the quarter ended March 31, 2026.

View on SEC.gov

Browse all earnings releases →

Ainos, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-022751

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.